David Scott Moore's most recent trade in Corvus Pharmaceuticals Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corvus Pharma Inc | David Scott Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2025 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |